Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Colorcon
Chubb
US Department of Justice
Mallinckrodt
Queensland Health
Deloitte
AstraZeneca
Cerilliant
Healthtrust

Generated: October 17, 2017

DrugPatentWatch Database Preview

Gemfibrozil - Generic Drug Details

« Back to Dashboard

What are the generic sources for gemfibrozil and what is the scope of gemfibrozil freedom to operate?

Gemfibrozil
is the generic ingredient in two branded drugs marketed by Impax Pharms, Caribe Holdings, Sandoz, Pfizer Pharms, Aurobindo Pharma Ltd, Purepac Pharm, Apotex, Invagen Pharms, Sun Pharm Inds Inc, Watson Labs, Mylan, Teva, Cadila Pharms Ltd, Chartwell Molecules, Northstar Hlthcare, and Hikma Pharms, and is included in nineteen NDAs. Additional information is available in the individual branded drug profile pages.

Fifty-one suppliers are listed for this compound. There is one tentative approval for this compound.

Summary for Generic Name: gemfibrozil

US Patents:0
Tradenames:2
Applicants:16
NDAs:19
Suppliers / Packagers: see list51
Bulk Api Vendors: see list69
Clinical Trials: see list32
Patent Applications: see list6,135
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:gemfibrozil at DailyMed

Pharmacology for Ingredient: gemfibrozil

Tentative approvals for GEMFIBROZIL

Applicant Application No. Strength Dosage Form
u► Subscribe300MGCAPSULE;ORAL
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan
GEMFIBROZIL
gemfibrozil
TABLET;ORAL074452-001Feb 16, 1995DISCNNoNo► Subscribe► Subscribe► Subscribe
Sandoz
GEMFIBROZIL
gemfibrozil
TABLET;ORAL074615-001Sep 29, 1995DISCNNoNo► Subscribe► Subscribe► Subscribe
Chartwell Molecules
GEMFIBROZIL
gemfibrozil
TABLET;ORAL074270-001Sep 27, 1993ABRXNoNo► Subscribe► Subscribe► Subscribe
Caribe Holdings
GEMFIBROZIL
gemfibrozil
TABLET;ORAL078012-001Mar 26, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe
Aurobindo Pharma Ltd
GEMFIBROZIL
gemfibrozil
TABLET;ORAL202726-001Sep 16, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Pfizer Pharms
LOPID
gemfibrozil
TABLET;ORAL018422-003Nov 20, 1986ABRXYesYes► Subscribe► Subscribe► Subscribe
Purepac Pharm
GEMFIBROZIL
gemfibrozil
CAPSULE;ORAL072929-001Jan 29, 1993DISCNNoNo► Subscribe► Subscribe► Subscribe
Teva
GEMFIBROZIL
gemfibrozil
TABLET;ORAL074256-001Oct 31, 1993ABRXNoNo► Subscribe► Subscribe► Subscribe
Impax Pharms
GEMFIBROZIL
gemfibrozil
TABLET;ORAL078207-001Jun 1, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe
Invagen Pharms
GEMFIBROZIL
gemfibrozil
TABLET;ORAL077836-001Jul 27, 2006ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: gemfibrozil

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer Pharms
LOPID
gemfibrozil
CAPSULE;ORAL018422-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Pfizer Pharms
LOPID
gemfibrozil
CAPSULE;ORAL018422-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
UBS
Argus Health
Baxter
Boehringer Ingelheim
Julphar
Johnson and Johnson
QuintilesIMS
Merck
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot